Protalix BioTherapeutics
PLX
#8714
Rank
โ‚ฌ98.44 M
Marketcap
1,34ย โ‚ฌ
Share price
13.71%
Change (1 day)
4.57%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -โ‚ฌ12.11 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚ฌ38.05 Million. In 2023 the company made an earning of โ‚ฌ11.15 Million, an increase over its 2022 earnings that were of -โ‚ฌ11.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ12.11 Million-208.44%
2023 โ‚ฌ11.15 M-199.05%
2022 -โ‚ฌ11.27 Million-40.38%
2021 -โ‚ฌ18.9 Million-732.31%
2020 โ‚ฌ2.98 M-130.53%
2019 -โ‚ฌ9.79 Million189.85%
2018 -โ‚ฌ3.38 Million-95.29%
2017 -โ‚ฌ71.73 Million308.12%
2016 -โ‚ฌ17.58 Million-32.37%
2015 -โ‚ฌ25.99 Million10.11%
2014 -โ‚ฌ23.61 Million-7.59%
2013 -โ‚ฌ25.54 Million
2011 -โ‚ฌ29.58 Million-19.39%
2010 -โ‚ฌ36.69 Million20.87%
2009 -โ‚ฌ30.36 Million32.26%
2008 -โ‚ฌ22.95 Million-5.46%
2007 -โ‚ฌ24.28 Million
2004 -โ‚ฌ0.16 Million12.35%
2003 -โ‚ฌ0.14 Million-11.1%
2002 -โ‚ฌ0.16 Million-57.03%
2001 -โ‚ฌ0.37 Million1.03%
2000 -โ‚ฌ0.37 Million-53.22%
1999 -โ‚ฌ0.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ94.79 Million 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.62 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.16 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.78 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel